Ftse Mib
33.898,22
0,80%
DAX
18.129,64
0,76%
S&P 500
5.157,34
0,58%
NASDAQ
16.258,75
0,63%
Bitcoin
64.018,86
0,03%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Virios Therapeutics Inc (VIRI) Virios Therapeutics Inc (VIRI) Notizie

Virios Therapeutics Inc

VIRI
0,4287
0,0172 (4,18%)
Ultimo aggiornamento: 15:50:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202415:15GLOBEVirios Therapeutics to Report First Quarter 2024 Financial..
26/3/202414:15GLOBEVirios Therapeutics Announces Publication of International..
08/3/202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/3/202422:30EDGAR2Form 8-K - Current report
01/3/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:25EDGAR2Form 8-K - Current report
29/2/202415:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
28/2/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:15GLOBEVirios Therapeutics Issues Shareholder Letter..
27/2/202422:15EDGAR2Form 8-K - Current report
02/2/202422:31EDGAR2Form DEF 14A - Other definitive proxy statements
22/1/202415:33EDGAR2Form PRE 14A - Other preliminary proxy statements
22/1/202415:00GLOBEVirios Therapeutics Announces Plans to Advance..
03/1/202413:05EDGAR2Form 8-K - Current report
02/1/202413:05GLOBEVirios Therapeutics, Inc. Reaches Alignment with FDA on..
13/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:20EDGAR2Form 8-K - Current report
13/11/202313:05GLOBEVirios Therapeutics Announces Third Quarter 2023 Financial..
07/11/202313:29EDGAR2Form 8-K - Current report
06/11/202313:05GLOBEVirios Therapeutics to Report Third Quarter 2023 Financial..
02/11/202312:05EDGAR2Form 8-K - Current report
12/10/202313:05GLOBEVirios Therapeutics to Present at the ThinkEquity Conference..
18/9/202313:16EDGAR2Form 8-K - Current report
18/9/202313:05GLOBEVirios Therapeutics Announces Termination of At-The-Market..
12/9/202313:05GLOBEVirios Therapeutics CEO Greg Duncan to Present at the..
22/8/202321:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202313:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:05GLOBEVirios Therapeutics Announces Halt to At-The-Market Offering..
11/8/202314:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:15EDGAR2Form 8-K - Current report
10/8/202313:05GLOBEVirios Therapeutics Announces Second Quarter 2023 Financial..
09/8/202313:15EDGAR2Form 8-K - Current report
09/8/202313:05GLOBEVirios Therapeutics Announces Plans to Advance Lead..
03/8/202322:05GLOBEVirios Therapeutics to Report Second Quarter 2023 Financial..
17/7/202313:15EDGAR2Form 8-K - Current report
17/7/202313:05GLOBEVirios Therapeutics Announces Positive Data Demonstrating..
14/7/202322:25EDGAR2Form 8-K - Current report
14/7/202322:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/5/202322:05GLOBEVirios Therapeutics Regains Compliance with Nasdaq Minimum..
15/5/202313:05GLOBEVirios Therapeutics Announces Submission of Final Toxicology..
11/5/202313:05GLOBEVirios Therapeutics Announces First Quarter 2023 Financial..
Apertura: 0,428 Min: 0,4111 Max: 0,4287
Chiusura: 0,4115

La tua Cronologia

NASDAQ
VIRI
Virios Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network